Acciones Rayont, Inc. Other OTC
Acciones
RAYT
US75508M1009
Biotecnología e investigación médica
Ventas 2021 | 2,97 M 2,76 M | Ventas 2022 | 2,84 M 2,64 M | Capitalización | 45,69 M 42,43 M |
---|---|---|---|---|---|
Resultado Neto 2021 | - 0 | Resultado Neto 2022 | - 0 | VE / Ventas 2021 | 47,8 x |
Deuda neta 2021 | 2,4 M 2,23 M | Deuda neta 2022 | 7,78 M 7,22 M | VE / Ventas 2022 | 18,8 x |
P/E ratio 2021 |
293
x | P/E ratio 2022 |
186
x | Empleados | - |
Rendimiento 2021 * |
-
| Rendimiento 2022 |
-
| Flotante | 48,18 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 48 | 31/03/20 | |
Ilenna Copley
COO | Chief Operating Officer | - | 16/05/22 |
Dhurata Toli
BRD | Director/Board Member | 48 | 25/03/21 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Jason Sunstein
BRD | Director/Board Member | 52 | 21/04/22 |
Dhurata Toli
BRD | Director/Board Member | 48 | 25/03/21 |
Chief Executive Officer | 48 | 31/03/20 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+17,96 % | 44,96 mil M | |
+1,17 % | 42,65 mil M | |
+48,77 % | 41,85 mil M | |
-4,27 % | 29,04 mil M | |
+11,42 % | 26,08 mil M | |
-21,39 % | 19,03 mil M | |
+4,86 % | 12,75 mil M | |
+27,29 % | 12,06 mil M | |
-3,50 % | 11,75 mil M |